Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- StataCorp LLC
- Proposal award date
- 2020-04-01
- Contract end date
- 2022-03-31
- UEI
- VUHZKNNX83J1
- Solicitation number
- PA19-272
- Topic code
- NCI
Research abstract
Project Summary
Interval-censored data arise frequently in clinical and epidemiological studies, because the time to the devel-
opment of an asymptomatic disease (e.g., tumor occurrence, HIV infection, onset of diabetes or hypertension)
cannot be observed exactly but rather is known to lie in a time interval between two consecutive clinical exam-
inations. Recent theoretical and computational advances in nonparametric maximum likelihood estimation of
semiparametric regression models with interval-censored data promise far more efficient and reliable analysis
than what is currently possible. The broad, long-term objective of this SBIR proposal is to create a suite of
commands, along with a companion text, in the widely used commercial software package Stata for performing
cutting-edge nonparametric maximum likelihood estimation of the familiar Cox proportional hazards model with
time-dependent covariates for interval-censored event times and for extending this methodology to multivariate
interval-censored event times, which arise when several asymptomatic diseases or recurrences of a particu-
lar disease are of interest or when study subjects are sampled in clusters (e.g., families, litters). The recently
completed Phase I of this project has successfully established the scientific merit and technical feasibility of the
proposed research and development effort by producing a prototype command for nonparametric maximum like-
lihood estimation of the Cox proportional hazards model with potentially time-dependent covariates for univariate
interval-censored data (i.e., a single event time for unrelated subjects) and by certifying the correctness of the
estimation results from the new command against results from published papers and research code. The Phase II
project will build on the success of the Phase I effort to develop a suite of reliable, robust, user-friendly, speed- and
memory- efficient commands for semiparametric regression analysis of interval-censored data. Specifically, the
Phase I code will be expanded substantially to incorporate stratification factors and likelihood ratio statistics (as
an alternative to the Wald statistics implemented in Phase I) for univariate interval-censored data, to fit marginal
Cox proportional hazards models for multiple diseases and clustered data and proportional rates/means models
for recurrent events, and to provide model-checking procedures for both univariate and multivariate models. The
correctness of the results will be certified in five clinical and epidemiological studies, and the sped-up code will be
converted into a commercial-grade program with a graphical user interface and comprehensive documentation.
Finally, a companion text will be written to document the software itself and serve as a substantive reference for
researchers new to the field. The software program produced by this SBIR project will be a part of the Stata pack-
age. This powerful and convenient software will enable biomedical investigators to analyze interval-censored data
in a statistically efficient and unbiased manner. As such, this new tool will facilitate the search for effective inter-
vention and prevention strategies for many common diseases (e.g., cancer, HIV/AIDS, diabetes, hypertension),
thereby leading to improvements in public health.Project Narrative
The broad, long-term objective of this SBIR project is to develop a suite of commands in the widely used commer-
cial software package Stata for performing statistical analysis of times to occurrence of asymptomatic diseases
that can only be detected through periodic clinical examinations. This powerful tool will enable clinical and epi-
demiological investigators to analyze this important type of biomedical data in a statistically efficient and unbiased
manner, thereby facilitating the discovery of effective intervention and prevention strategies for many diseases of
utmost public health significance, including cancer, HIV/AIDS, diabetes, and hypertension.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
14 SBIR/STTR records share this UEI (1997–2020). Reported award amounts total $5,106,617. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards